Kyung Nam Pharm Co Ltd (053950) — Cash Flow Reinvestment Rate
Kyung Nam Pharm Co Ltd (053950) has a Cash Flow Reinvestment Rate of 0.20x as of September 2025, reinvesting ₩147.39 Million (capex ₩147.39 Million ) from operating cash flow of ₩748.10 Million. Check Kyung Nam Pharm Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kyung Nam Pharm Co Ltd Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Kyung Nam Pharm Co Ltd across 8 annual periods. Explore 053950 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Kyung Nam Pharm Co Ltd (2007–2024)
Year-by-year capital reinvestment analysis for Kyung Nam Pharm Co Ltd. For live market cap and broader valuation context, see Kyung Nam Pharm Co Ltd (053950) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.10x | ₩3.85 Billion | ₩1.84 Billion | ₩1.67 Billion | ▼ -88.3% |
| 2023 | 17.89x | ₩12.40 Billion | ₩693.30 Million | ₩4.18 Billion | ▼ -62.5% |
| 2022 | 47.75x | ₩3.42 Billion | ₩71.58 Million | ₩2.92 Billion | ▲ +153.1% |
| 2020 | 18.86x | ₩49.33 Billion | ₩2.62 Billion | ₩45.58 Billion | ▲ +2969.4% |
| 2017 | 0.61x | ₩1.06 Billion | ₩1.72 Billion | ₩1.05 Billion | ▲ +170.9% |
| 2016 | 0.23x | ₩1.11 Billion | ₩4.89 Billion | ₩1.11 Billion | ▼ -99.0% |
| 2010 | 22.56x | ₩10.89 Billion | ₩482.65 Million | ₩10.89 Billion | ▼ -15.9% |
| 2007 | 26.83x | ₩3.99 Billion | ₩148.79 Million | ₩3.99 Billion | — |